K
Kathryn Foucar
Researcher at University of New Mexico
Publications - 63
Citations - 2270
Kathryn Foucar is an academic researcher from University of New Mexico. The author has contributed to research in topics: Bone marrow & Myeloid leukemia. The author has an hindex of 22, co-authored 56 publications receiving 1628 citations.
Papers
More filters
Journal ArticleDOI
International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data.
Daniel A. Arber,Attilio Orazi,Robert P. Hasserjian,Michael Horowitz,Katherine R. Calvo,Hans Michael Kvasnicka,Sa A. Wang,Adam Bagg,Tiziano Barbui,Susan Branford,Carlos E. Bueso-Ramos,Jorge E. Cortes,Paola Dal Cin,Courtney D. DiNardo,Hervé Dombret,Eric J. Duncavage,Benjamin L. Ebert,Elihu H. Estey,Fabio Facchetti,Kathryn Foucar,Naseema Gangat,Umberto Gianelli,Lucy A. Godley,Nicola Goekbuget,Jason Gotlib,Eva Hellström-Lindberg,Gabriela S. Hobbs,Roald Hoffmann,Elias Jabbour,Jean-Jacques Kiladjian,Richard A. Larson,Michelle M. Le Beau,Mignon L. Loh,Bob Löwenberg,Elizabeth Macintyre,Luca Malcovati,Charles G. Mullighan,Charlotte M. Niemeyer,Olatoyosi Odenike,Seishi Ogawa,Alberto Orfao,Elli Papaemmanuil,Francesco Passamonti,Kimmo Porkka,C H Pui,Jerald P. Radich,Andreas Reiter,María Rozman,Martina Rudelius,Michael R. Savona,Charles A. Schiffer,Annette Schmitt-Graeff,Akiko Shimamura,Jorge Sierra,Wendy Stock,Richard Stone,Martin S. Tallman,Juergen Thiele,Hwei-Fang Tien,Alexandar Tzankov,Alessandro M. Vannucchi,Paresh Vyas,Andrew H. Wei,Olga Weinberg,Agnieszka Wierzbowska,Mario Cazzola,Hartmut Döhner,Ayalew Tefferi +67 more
TL;DR: The authors, a group with expertise in the clinical, pathologic and genetic aspects of these disorders, developed the International Consensus Classification (ICC), aimed at facilitating diagnosis and prognostication of these neoplasms, improving treatment of affected patients, and allowing the design of innovative clinical trials.
Journal ArticleDOI
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms
Sa A. Wang,Robert P. Hasserjian,Patricia S. Fox,Heesun J. Rogers,Julia T. Geyer,Devon Chabot-Richards,Elizabeth Weinzierl,Joseph Hatem,Jesse Jaso,Rashmi Kanagal-Shamanna,Francesco C. Stingo,Keyur P. Patel,Meenakshi Mehrotra,Carlos E. Bueso-Ramos,Ken H. Young,Courtney D. DiNardo,Srdan Verstovsek,Ramon V. Tiu,Adam Bagg,Eric D. Hsi,Daniel A. Arber,Kathryn Foucar,Raja Luthra,Attilio Orazi +23 more
TL;DR: Within MDS/MPN, the World Health Organization 2008 criteria for aCML identify a subgroup of patients with features clearly distinct from MDS /MPN-U, which is heterogeneous and patient risk can be further stratified by a number of clinicopathological parameters.
Journal ArticleDOI
Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia
David R. Head,Kenneth J. Kopecky,James K. Weick,Joe C. Files,Donna H. Ryan,Kathryn Foucar,Milka Montiel,John Bickers,Andrew J. Fishleder,Michael E. Miller,Catherine M. Spier,Curtis A. Hanson,Mitch Bitter,Rita M. Braziel,Glenn Mills,Jeanna L Welborn,Wilbur Williams,James S. Hewlett,Cheryl L. Willman,Frederick R. Appelbaum +19 more
TL;DR: It is concluded that high-dose DNR selectively increases survival in APL, important for evaluation of combined all-trans retinoic acid (ATRA)/chemotherapy protocols and for planning future combinations of chemotherapy and ATRA.
Journal ArticleDOI
Myelodysplastic/myeloproliferative neoplasms.
TL;DR: This SHP/EAHP Workshop session was uniquely problematic owing to the overlap between MDS/MPNs and both chronic myeloproliferative neoplasms and myelodysplasia.